Cargando…
Decabromodiphenyl ether causes insulin resistance and glucose and lipid metabolism disorders in mice
BACKGROUND: Decabromodiphenyl ether (BDE-209) is the most commonly used brominated flame retardant. Recently, BDE-209 has been suspected of being an environmental risk factor for metabolic diseases such as obesity, insulin resistance (IR), type 2 diabetes mellitus, and hypertension. AIM: To investig...
Autores principales: | Alimu, Ayiguli, Abudureman, Haiqiemuhan, Wang, Yong-Zhi, Li, Mei-Yan, Wang, Jia-Sui, Liu, Zao-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394237/ https://www.ncbi.nlm.nih.gov/pubmed/34512892 http://dx.doi.org/10.4239/wjd.v12.i8.1267 |
Ejemplares similares
-
Endocrine disrupting and carcinogenic effects of decabromodiphenyl ether
por: Wang, Yi, et al.
Publicado: (2023) -
Microbial Electricity Generation Enhances Decabromodiphenyl Ether (BDE-209) Degradation
por: Yang, Yonggang, et al.
Publicado: (2013) -
Pollution Status and Human Exposure of Decabromodiphenyl
Ether (BDE-209) in China
por: Ji, Xiaowen, et al.
Publicado: (2017) -
Long-Term Exposure to Decabromodiphenyl Ether Promotes the Proliferation and Tumourigenesis of Papillary Thyroid Carcinoma by Inhibiting TRß
por: Wang, Xinpei, et al.
Publicado: (2022) -
Toxic effects of decabromodiphenyl ether (BDE-209) on human embryonic kidney cells
por: Li, Min, et al.
Publicado: (2014)